Anupam Rasayan India Limited announced robust consolidated financial results for the quarter ending December 31, 2025 (Q3FY26). Total revenue surged by 33% Year-over-Year (YoY) to ₹5,145 Million. EBITDA saw a 7% YoY increase, reaching ₹1,296 Million, while Profit After Tax (PAT) grew by 12% YoY to ₹606 Million. Management also highlighted the strategic agreement to acquire Jayhawk Fine Chemicals Corporation in the US.
Anupam Rasayan Reports Strong Q3FY26 Performance
Anupam Rasayan India Ltd. (ARIL), a leading custom synthesis and specialty chemical player, has disclosed its financial outcomes for the quarter ended December 31, 2025. The results demonstrate continued strong momentum across its core businesses.
Consolidated Financial Highlights for Q3FY26
The company reported significant year-over-year improvements for the third quarter:
- Total Revenue: ₹5,145 Million, reflecting a substantial 33% YoY growth compared to ₹3,866 Million in Q3FY25.
- EBITDA (including other income): Grew by 7% YoY to ₹1,296 Million, translating to an EBITDA margin of 25.20% for the quarter.
- Profit After Tax (PAT): Increased by 12% YoY, reaching ₹606 Million, up from ₹542 Million in the corresponding period last year.
Nine-Month Performance and Management Commentary
For the cumulative nine months of FY26, the company delivered consolidated revenue of ₹17,297 Million with an EBITDA of ₹4,024 Million, signaling sustained high growth rates.
Commenting on the performance, Mr. Anand Desai, Managing Director, expressed satisfaction with the results, stating that Q3 FY26 revenue stood at ₹5,124 Million with EBITDA of ₹1,296 Million, confirming the “continued growth momentum.”
Key Strategic Development: US Acquisition
A major strategic milestone achieved during the quarter was the signing of a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States. Mr. Desai noted that this acquisition is crucial as it:
- Strengthens ARIL’s global footprint.
- Enhances capabilities in advanced custom synthesis.
- Deepens access to regulated markets and innovator customers across North America.
This move is positioned as an important step toward establishing Anupam Rasayan as a truly global specialty chemical platform.
About Anupam Rasayan India Ltd. (ARIL)
ARIL is recognized as a leading company in custom synthesis (CSM) and specialty chemicals manufacturing in India, established in 1984. The company focuses on two main verticals: Life science related Specialty Chemicals (Agrochemicals, Personal Care, Pharmaceuticals) and Other Specialty Chemicals (Polymer Additives). ARIL currently serves over 75 domestic and international customers, including 31 multinational companies, operating through six manufacturing facilities in Gujarat.
Source: BSE
